Compare Nuwellis Inc (NUWE) vs YieldMax Magnificent 7 Fund of Option Income ETFs (YMAG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? Nuwellis Inc trades at $2.95 (market cap $1.09M), while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.67. The key difference: YieldMax Magnificent 7 Fund of Option Income ETFs is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | YMAG | |
|---|---|---|
Market Cap | $1.09M | — |
Sector | Technology | Income / Options Overlay |
52-Week High | $527.46 | $15.98 |
52-Week Low | $2.80 | $11.00 |
Enterprise Value | -$722.58K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About YieldMax Magnificent 7 Fund of Option Income ETFs
YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.
Read more on YMAG →
